HCA Healthcare, Inc.
HCA- Exchange
- NYSE
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- SEC CIK
- 0000860730
No open-market purchases or sales by HCA Healthcare, Inc. insiders were filed in the last 90 days; 1,343 institutions reported holding it in 13F filings for Q2 2026, worth $51.2B in total; superinvestors Harris Associates (Oakmark) and Markel Group hold it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by HCA Healthcare, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for HCA Healthcare, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| McAlevey Michael R | EVP & Chief Legal & Admin Off. | 0Indirect | Aug 28, 2026 | 5 |
| Marks Mike A | EVP and CFO | 46,576Indirect | May 11, 2026 | 4 |
| Chidsey John | Director | 1,305 | Apr 30, 2026 | 1 |
| Deparle Nancy Ann | Director | 21,910 | Apr 30, 2026 | 1 |
| Michelson Michael W | Director | 12,576 | Apr 30, 2026 | 1 |
| Frist Thomas F III | Director, 10% Owner | 15,858 | Apr 30, 2026 | 2 |
| Johnston Hugh F | Director | 4,475 | Apr 30, 2026 | 1 |
| Riley Wayne Joseph | Director | 15,029 | Apr 30, 2026 | 1 |
| Frist William R | Director, 10% Owner | 13,740 | Apr 30, 2026 | 2 |
| Smith Andrea B | Director | 4,666 | Apr 30, 2026 | 1 |
| Hazen Samuel N | CEO | 64,842 | Feb 12, 2026 | 5 |
| Foster Jon M | EVP and COO | 23,062 | Feb 12, 2026 | 3 |
| Cuffe Michael S. | EVP and Chief Clinical Officer | 32,080 | Feb 12, 2026 | 3 |
| Wyatt Christopher F. | SVP & Controller | 44,379 | Feb 12, 2026 | 3 |
| Berres Jennifer | SVP & Chief Human Res. Officer | 11,993 | Feb 12, 2026 | 2 |
| Rossitto Erica | SVP & Chief Nurse Executive | 10,407 | Feb 12, 2026 | 1 |
| Frist Thomas F Jr | 10% Owner | 36,557,141Indirect | Feb 10, 2026 | 1 |
| Hercules Holding II | 10% Owner | 32,282,889 | Feb 10, 2026 | 1 |
| Frisco Holding II | 10% Owner | 36,557,141 | Feb 10, 2026 | 1 |
| Elcan Patricia F | 10% Owner | 36,557,141Indirect | Feb 10, 2026 | 1 |
| Dennis Robert J | Director | 26,601 | May 1, 2025 | 0 |
| Bank Of America Corp | 10% Owner | 0Indirect | Mar 28, 2025 | 0 |
| Merrill Lynch, Pierce, Fenner & Smith Inc. | 10% Owner | 0Indirect | Mar 28, 2025 | 0 |
| Bank Of America NA | 10% Owner | 0Indirect | Mar 28, 2025 | 0 |
| Mosier Sammie S | SVP & Chief Nurse Executive | 11,113 | Feb 18, 2025 | 0 |
| Whalen Kathleen M | SVP & Chief Ethics Officer | 9,454 | Nov 18, 2024 | 0 |
| Billington Phillip G | SVP-Internal Audit Services | 52,702 | Nov 14, 2024 | 0 |
| Akdamar Erol R | Group President | 6,843 | Nov 14, 2024 | 0 |
| Sowell Joseph A III | SVP; Chief Development Officer | 18,526Indirect | Aug 7, 2024 | 0 |
| McManus Timothy M | Group President | 27,008 | Aug 2, 2024 | 0 |
| Reiner Deborah M | SVP - Mktg. & Communications | 3,510 | Jul 31, 2024 | 0 |
| Torres Kathryn A. | SVP-Payer Contracting & Align. | 17,755 | Jul 29, 2024 | 0 |
| Cohen Jeffrey E. | SVP-Government Relations | 5,185 | May 13, 2024 | 0 |
| Crofton Meg | Director | 6,331 | May 1, 2024 | 0 |
| Wasserman Chad J | SVP and CIO | 1,576 | Mar 20, 2024 | 0 |
| Rutherford Bill B | CFO and EVP | 22,251 | Feb 21, 2024 | 0 |
| Hammett Richard A | Group President | 17,936 | Feb 21, 2024 | 0 |
| Paslick P. Martin | SVP and CIO | 24,643 | Apr 14, 2023 | 0 |
| Moore A Bruce Jr | Group President - Service Line | 30,807 | Nov 15, 2022 | 0 |
| Hall Charles J | Group President | 202,443 | Nov 15, 2022 | 0 |
| Holliday Charles O Jr | Director | 18,955 | Apr 27, 2022 | 0 |
| Englebright Jane D. | SVP and Chief Nursing Officer | 0 | Nov 12, 2021 | 0 |
| Perlin Jonathan B | Pres-Clinical Operations & CMO | 44,348Indirect | Aug 4, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 23, 2021 (view filing) | Jul 21 | 2 days | Torres Kathryn A.SVP-Payer Contracting & Align. | SSale | −1.00K | $252.00 | −$252.0K | −5.9%15.9K after | |
| Jul 26, 2021 (view filing) | Jul 22 | 4 days | Whalen Kathleen MSVP & Chief Ethics Officer | SSale | −886 | $246.90 | −$218.8K | −9.1%8.88K after | |
| Jul 29, 2021 (view filing) | Jul 29 | Same day | Englebright Jane D.SVP and Chief Nursing Officer | SSale | −200 | $249.36 | −$49.9K | −2.7%7.33K after | |
| Jul 29, 2021 (view filing) | Jul 27 | 2 days | Hall Charles JGroup President | SSale | −3.00K | $249.94 | −$749.8K | −1.5%203.9K after | |
| Jul 29, 2021 (view filing) | Jul 27 | 2 days | Paslick P. MartinSVP and CIO | SSale | −7.47K | $250.00 | −$1.87M | −36.7%12.9K after | |
| Aug 3, 2021 (view filing) | Jul 30-Aug 2 | 4 days | Englebright Jane D.SVP and Chief Nursing Officer | SSale | −3.31K | $249.45 | −$825.4K | −45.2%4.02K after | 2 lots |
| Aug 4, 2021 (view filing) | Aug 2-3 | 2 days | Hall Charles JGroup President | SSale | −9.00K | $252.27 | −$2.27M | −4.4%194.9K after | 3 lots |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Perlin Jonathan BPres-Clinical Operations & CMO | SSale | −40.0K | $250.00 | −$10.0M | −47.4%44.3K after | 4 lots |
| Aug 5, 2021 (view filing) | Aug 3 | 2 days | Cuffe Michael S.President-Physician Services | SSale | −2.50K | $251.91 | −$629.8K | −12.2%17.9K after | |
| Aug 9, 2021 (view filing) | Aug 5 | 4 days | Englebright Jane D.SVP and Chief Nursing Officer | SSale | −4.02K | $250.12 | −$1.00M | −100.0%0 after | |
| Nov 2, 2021 (view filing) | Nov 2 | Same day | Hazen Samuel NCEO | SSale | −50.0K | $251.73 | −$12.6M | −13.4%323.7K after | 3 lots |
| Nov 4, 2021 (view filing) | Nov 4 | Same day | Whalen Kathleen MSVP & Chief Ethics Officer | SSale | −3.81K | $250.48 | −$955.6K | −30.1%8.88K after | |
| Nov 5, 2021 (view filing) | Nov 3-4 | 2 days | Rutherford Bill BCFO and EVP | SSale | −30.0K | $250.00 | −$7.50M | −34.1%58.0K after | 2 lots |
| Nov 9, 2021 (view filing) | Nov 5 | 4 days | Wyatt Christopher F.SVP & Controller | SSale | −2.10K | $252.94 | −$531.2K | −7.0%27.8K after | |
| Nov 10, 2021 (view filing) | Nov 10 | Same day | Billington Phillip GSVP-Internal Audit Services | SSale | −8.25K | $246.26 | −$2.03M | −18.2%37.1K after | |
| Nov 12, 2021 (view filing) | Nov 9 | 3 days | Englebright Jane D.SVP and Chief Nursing Officer | SSale | −3.36K | $249.61 | −$839.7K | −100.0%0 after | |
| Nov 12, 2021 (view filing) | Nov 11 | 1 day | Foster Jon MGroup President | SSale | −16.3K | $241.64 | −$3.94M | −100.0%0 after | 3 lots |
| Nov 12, 2021 (view filing) | Nov 10 | 2 days | Reiner Deborah MSVP - Mktg. & Communications | SSale | −2.05K | $246.23 | −$505.3K | −31.2%4.52K after | |
| Jan 6, 2022 (view filing) | Jan 4 | 2 days | Sowell Joseph A IIISVP; Chief Development Officer | SSale | −22.2K | $259.23 | −$5.75M | −64.2%12.4K after | |
| Feb 18, 2022 (view filing) | Feb 16-17 | 2 days | Moore A Bruce JrGroup President - Service Line | SSale | −30.0K | $246.87 | −$7.41M | −24.6%91.8K after | 2 lots |
| Mar 15, 2022 (view filing) | Mar 11 | 4 days | Sowell Joseph A IIISVP; Chief Development Officer | SSale | −11.5K | $269.00 | −$3.10M | −40.3%17.1K after | |
| May 2, 2022 (view filing) | Apr 28 | 4 days | Smith Andrea BDirector | PPurchase | +1.16K | $213.63 | +$247.8K | +107.5%2.24K after | |
| May 3, 2022 (view filing) | Apr 29 | 4 days | McAlevey Michael RSVP & Chief Legal Officer | PPurchase | +1.11K | $218.56 | +$242.6K | New position1.11K after | |
| May 4, 2022 (view filing) | May 2 | 2 days | Frist Thomas F Jr10% Owner | PPurchaseCommon Stock, par value $0.01 per share | +89.1K | $211.93 | +$18.9M | +22.9%479.0K after | 7 lots |
| May 5, 2022 (view filing) | May 3 | 2 days | Whalen Kathleen MSVP & Chief Ethics Officer | SSale | −500 | $215.38 | −$107.7K | −4.2%11.4K after | |
| May 17, 2022 (view filing) | May 13 | 4 days | Berres JenniferSVP & Chief Human Res. Officer | SSale | −2.36K | $218.87 | −$516.1K | −17.1%11.4K after | |
| Jul 27, 2022 (view filing) | Jul 25 | 2 days | Elcan Patricia F10% Owner | PPurchaseCommon Stock, par value $0.01 per share | +325 | $198.66 | +$64.6K | +0.4%89.3K after | |
| Oct 26, 2022 (view filing) | Oct 24 | 2 days | Torres Kathryn A.SVP-Payer Contracting & Align. | SSale | −2.00K | $203.30 | −$406.6K | −8.9%20.4K after | 2 lots |
| Oct 28, 2022 (view filing) | Oct 28 | Same day | Billington Phillip GSVP-Internal Audit Services | SSale | −8.33K | $222.58 | −$1.85M | −17.0%40.7K after | |
| Nov 1, 2022 (view filing) | Oct 28 | 4 days | Sowell Joseph A IIISVP; Chief Development Officer | SSale | −12.9K | $223.18 | −$2.89M | −100.0%0 after | |
| Nov 1, 2022 (view filing) | Oct 28 | 4 days | Hall Charles JGroup President | SSale | −9.84K | $223.50 | −$2.20M | −4.7%199.9K after | |
| Nov 15, 2022 (view filing) | Nov 11 | 4 days | Moore A Bruce JrGroup President - Service Line | SSale | −10.0K | $224.07 | −$2.24M | −24.5%30.8K after | |
| Feb 1, 2023 (view filing) | Feb 1 | Same day | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −4.00K | $257.11 | −$1.03M | −16.1%20.8K after | |
| Feb 1, 2023 (view filing) | Feb 1 | Same day | Foster Jon MEVP and COO | SSale | −16.4K | $251.98 | −$4.14M | −60.0%10.9K after | |
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | McManus Timothy MGroup President | SSale | −7.90K | $254.06 | −$2.01M | −36.1%14.0K after | 2 lots |
| Feb 1, 2023 (view filing) | Feb 1 | Same day | Paslick P. MartinSVP and CIO | SSale | −1.00K | $256.95 | −$256.9K | −25.0%3.00K after | |
| Feb 1, 2023 (view filing) | Feb 1 | Same day | Wyatt Christopher F.SVP & Controller | SSale | −4.90K | $253.30 | −$1.24M | −13.1%32.4K after | |
| Feb 3, 2023 (view filing) | Feb 3 | Same day | Rutherford Bill BCFO and EVP | SSale | −30.0K | $258.19 | −$7.75M | −26.9%81.6K after | |
| Feb 6, 2023 (view filing) | Feb 2 | 4 days | Akdamar Erol RGroup President | SSale | −3.00K | $258.63 | −$775.9K | −8.0%34.7K after | |
| Feb 7, 2023 (view filing) | Feb 3 | 4 days | Reiner Deborah MSVP - Mktg. & Communications | SSale | −7.94K | $257.61 | −$2.05M | −100.0%0 after | |
| Feb 9, 2023 (view filing) | Feb 7 | 2 days | Berres JenniferSVP & Chief Human Res. Officer | SSale | −4.00K | $255.23 | −$1.02M | −35.1%7.39K after | |
| Feb 22, 2023 (view filing) | Feb 17 | 5 days | Whalen Kathleen MSVP & Chief Ethics Officer | SSale | −1.73K | $263.61 | −$457.1K | −14.8%9.96K after | |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Paslick P. MartinSVP and CIO | SSale | −3.03K | $265.00 | −$804.0K | −11.0%24.6K after | |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Paslick P. MartinSVP and CIO | SSale | −2.54K | $270.00 | −$685.5K | −9.3%24.6K after | |
| Apr 14, 2023 (view filing) | Apr 14 | Same day | Paslick P. MartinSVP and CIO | SSale | −2.69K | $275.00 | −$738.9K | −9.8%24.6K after | |
| Apr 26, 2023 (view filing) | Apr 24 | 2 days | Torres Kathryn A.SVP-Payer Contracting & Align. | SSale | −4.47K | $288.38 | −$1.29M | −16.7%22.2K after | |
| May 2, 2023 (view filing) | Apr 28 | 4 days | Akdamar Erol RGroup President | SSale | −3.50K | $285.00 | −$997.5K | −7.6%42.5K after | |
| May 2, 2023 (view filing) | Apr 28 | 4 days | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −12.6K | $284.44 | −$3.57M | −30.4%28.8K after | |
| Aug 7, 2023 (view filing) | Aug 3 | 4 days | Whalen Kathleen MSVP & Chief Ethics Officer | SSale | −2.92K | $270.00 | −$787.3K | −22.1%10.3K after | |
| Aug 15, 2023 (view filing) | Aug 11 | 4 days | Cohen Jeffrey E.SVP-Government Relations | SSale | −1.50K | $270.00 | −$405.0K | −25.4%4.41K after |